[시장보고서]나노의학 시장 : 세계 산업 규모, 점유율, 동향, 기회, 예측 - 나노분자 유형별, 나노입자 유형별, 질환 적응증별 용도별, 지역별, 경쟁별(2020-2030년)

나노의학 시장 : 세계 산업 규모, 점유율, 동향, 기회, 예측 - 나노분자 유형별, 나노입자 유형별, 질환 적응증별 용도별, 지역별, 경쟁별(2020-2030년)

Nanomedicine Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Nanomolecule Type, By Nanoparticles Type, By Application By Disease Indication, By Region and Competition, 2020-2030F

상품코드 : 1878846

리서치사 : TechSci Research

발행일 : 2025년 11월

페이지 정보 : 영문 180 Pages

라이선스 & 가격 (부가세 별도)

US $ 4,500

￦ 6,681,000

Unprintable PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며, 텍스트의 Copy&Paste도 불가능합니다.

US $ 5,500

￦ 8,165,000

PDF and Excel (Multi-User License)

PDF 및 Excel 보고서를 기업의 팀이나 기관에서 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 및 Excel 이용 범위와 동일합니다.

US $ 8,000

￦ 11,877,000

PDF and Excel (Custom Research License)

PDF 및 Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 및 Excel 이용 범위와 동일합니다. 80시간의 애널리스트 타임이 포함되어 있고 Copy & Paste 가능한 PPT 버전도 제공됩니다. 짧은 Bespoke 리서치 프로젝트 수행에 맞는 라이선스입니다.

ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.

한글목차

샘플 요청 목록에 추가

세계의 나노의학 시장은 2024년에 1,741억 달러로 평가되었으며, 2030년까지 CAGR 9.10%로 성장하여 2,935억 9,000만 달러에 달할 것으로 예측됩니다.

나노의학은 헬스케어 분야에서 나노기술을 응용하여 질병의 진단, 치료, 예방을 위해 보통 1-100나노미터 범위의 재료와 장치를 활용하는 것을 말합니다. 이 접근법은 나노스케일 구조의 특성을 활용하여 약물의 용해도, 안정성, 표적 전달성, 생체 이용률을 향상시킵니다.

시장 개요
예측 기간	2026-2030년
시장 규모 : 2024년	1,741억 달러
시장 규모 : 2030년	2,935억 9,000만 달러
CAGR : 2025-2030년	9.1%
가장 빠르게 성장하는 부문	나노입자
최대 시장	북미

주요 시장 촉진요인

주요 시장 과제

주요 시장 동향

시장 규모 및 예측
- 금액별
시장 점유율과 예측
- 나노분자 유형별(나노입자, 나노쉘, 나노디바이스, 나노튜브)
- 나노입자 유형별(폴리머계, 지질계, 나노결정, 무기계, 기타)
- 용도별(약물전달, 백신, 진단 영상, 재생의료, 기타)
- 질환별(종양성 질환, 감염증, 정형외과 질환, 심혈관질환, 기타)
- 지역별
- 기업별(2024)
시장 맵

제6장 북미의 나노의학 시장 전망

시장 규모 및 예측
시장 점유율과 예측
북미 : 국가별 분석
- 미국
- 캐나다
- 멕시코

제7장 유럽의 나노의학 시장 전망

시장 규모 및 예측
시장 점유율과 예측
유럽 : 국가별 분석
- 독일
- 프랑스
- 영국
- 이탈리아
- 스페인

제8장 아시아태평양의 나노의학 시장 전망

시장 규모 및 예측
시장 점유율과 예측
아시아태평양 : 국가별 분석
- 중국
- 인도
- 일본
- 한국
- 호주

제9장 중동 및 아프리카의 나노의학 시장 전망

시장 규모 및 예측
시장 점유율과 예측
중동 및 아프리카 : 국가별 분석
- 사우디아라비아
- 아랍에미리트
- 남아프리카공화국

제10장 남미의 나노의학 시장 전망

시장 규모 및 예측
시장 점유율과 예측
남미 : 국가별 분석
- 브라질
- 콜롬비아
- 아르헨티나

제11장 시장 역학

성장 촉진요인
과제

제12장 시장 동향과 발전

인수합병
제품 출시
최근 동향

제13장 세계의 나노의학 시장 : SWOT 분석

제14장 Porter's Five Forces 분석

업계내 경쟁
신규 참여의 가능성
공급업체의 능력
고객의 능력
대체품의 위협

제15장 경쟁 구도

Pfizer Inc.
Johnson & Johnson Innovative Medicine
Sanofi S.A.
Amgen Inc.
Moderna, Inc.
Novo Nordisk A/S
Genentech, Inc.
Celgene Corporation
Vifor Pharma Group
Teva Pharmaceutical Industries Ltd.

제16장 전략적 제안

제17장 조사 회사 소개 및 면책사항

KSM

영문 목차

영문목차

The Global Nanomedicine Market, valued at USD 174.10 Billion in 2024, is projected to experience a CAGR of 9.10% to reach USD 293.59 Billion by 2030. Nanomedicine represents the application of nanotechnology in healthcare, utilizing materials and devices typically ranging from 1 to 100 nanometers for the diagnosis, treatment, and prevention of diseases. This approach leverages the unique properties of nanoscale structures to enhance drug solubility, stability, targeted delivery, and bioavailability.

Market Overview
Forecast Period	2026-2030
Market Size 2024	USD 174.10 Billion
Market Size 2030	USD 293.59 Billion
CAGR 2025-2030	9.1%
Fastest Growing Segment	Nanoparticles
Largest Market	North America

Key Market Drivers

The global nanomedicine market experiences significant impetus from two primary factors: ongoing advancements in nanotechnology innovation and the increasing prevalence of chronic diseases. Technological progress consistently yields novel tools and materials, enabling sophisticated diagnostic and therapeutic applications within healthcare. For instance, according to the National Institutes of Health, in July 2023, the Notice of Funding Opportunity for "Innovative Research in Cancer Nanotechnology (IRCN) R01 Grant" was published, with application deadlines including November 2023 and May 2024, demonstrating sustained investment in fundamental research in this specialized area. Concurrently, the rising global burden of chronic diseases intensifies the demand for more effective medical interventions.

Key Market Challenges

A significant challenge impeding the expansion of the Global Nanomedicine Market is the substantial cost associated with the development and complex manufacturing processes of these specialized products. The intricate nature of nanotechnology-based interventions necessitates considerable upfront investment in research, highly specialized equipment, advanced infrastructure, and a workforce with unique expertise. These requirements often lead to protracted development timelines and increased operational expenditures throughout the product lifecycle, from initial synthesis to large-scale production.

Key Market Trends

The increasing shift towards personalized nanomedicine stands as a significant factor shaping the global nanomedicine market. This trend emphasizes tailoring medical treatments to individual patient characteristics, leveraging nanotechnology's ability to deliver drugs precisely and enhance diagnostic accuracy. Personalized nanomedicine offers the potential for improved therapeutic efficacy and reduced adverse effects by targeting specific cells or tissues. According to the Personalized Medicine Coalition (PMC), a US-based nonprofit organization, the U. S. Food and Drug Administration (FDA) approved 26 new personalized medicines in 2023, a notable increase from the 12 approved in 2022. This demonstrates a growing regulatory recognition and market adoption of personalized approaches, which nanomedicine profoundly supports.

Key Market Players

Pfizer Inc.
Johnson & Johnson Innovative Medicine
Sanofi S.A.
Amgen Inc.
Moderna, Inc.
Novo Nordisk A/S
Genentech, Inc.
Celgene Corporation
Vifor Pharma Group
Teva Pharmaceutical Industries Ltd.

Report Scope:

In this report, the Global Nanomedicine Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Nanomedicine Market, By Nanomolecule Type:

Nanoparticles
Nanoshells
Nanodevices
Nanotubes

Nanomedicine Market, By Nanoparticles Type:

Polymer-based
Lipid-based
Nanocrystals
Inorganic
Others

Nanomedicine Market, By Application:

Drug Delivery
Vaccines
Diagnostic Imaging
Regenerative Medicine
Others

Nanomedicine Market, By Disease Indication:

Oncological Diseases
Infectious Diseases
Orthopedic Disorders
Cardiovascular Diseases
Others

Nanomedicine Market, By Region:

North America
- United States
- Canada
- Mexico
Europe
- France
- United Kingdom
- Italy
- Germany
- Spain
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
South America
- Brazil
- Argentina
- Colombia
Middle East & Africa
- South Africa
- Saudi Arabia
- UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Nanomedicine Market.

Available Customizations:

Global Nanomedicine Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

1. Product Overview

1.1. Market Definition
1.2. Scope of the Market
- 1.2.1. Markets Covered
- 1.2.2. Years Considered for Study
- 1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Nanomedicine Market Outlook

5.1. Market Size & Forecast
- 5.1.1. By Value
5.2. Market Share & Forecast
- 5.2.1. By Nanomolecule Type (Nanoparticles, Nanoshells, Nanodevices, Nanotubes)
- 5.2.2. By Nanoparticles Type (Polymer-based, Lipid-based, Nanocrystals, Inorganic, Others)
- 5.2.3. By Application (Drug Delivery, Vaccines, Diagnostic Imaging, Regenerative Medicine, Others)
- 5.2.4. By Disease Indication (Oncological Diseases, Infectious Diseases, Orthopedic Disorders, Cardiovascular Diseases, Others)
- 5.2.5. By Region
- 5.2.6. By Company (2024)
5.3. Market Map

6. North America Nanomedicine Market Outlook

6.1. Market Size & Forecast
- 6.1.1. By Value
6.2. Market Share & Forecast
- 6.2.1. By Nanomolecule Type
- 6.2.2. By Nanoparticles Type
- 6.2.3. By Application
- 6.2.4. By Disease Indication
- 6.2.5. By Country
6.3. North America: Country Analysis
- 6.3.1. United States Nanomedicine Market Outlook
  - 6.3.1.1. Market Size & Forecast
    - 6.3.1.1.1. By Value
  - 6.3.1.2. Market Share & Forecast
    - 6.3.1.2.1. By Nanomolecule Type
    - 6.3.1.2.2. By Nanoparticles Type
    - 6.3.1.2.3. By Application
    - 6.3.1.2.4. By Disease Indication
- 6.3.2. Canada Nanomedicine Market Outlook
  - 6.3.2.1. Market Size & Forecast
    - 6.3.2.1.1. By Value
  - 6.3.2.2. Market Share & Forecast
    - 6.3.2.2.1. By Nanomolecule Type
    - 6.3.2.2.2. By Nanoparticles Type
    - 6.3.2.2.3. By Application
    - 6.3.2.2.4. By Disease Indication
- 6.3.3. Mexico Nanomedicine Market Outlook
  - 6.3.3.1. Market Size & Forecast
    - 6.3.3.1.1. By Value
  - 6.3.3.2. Market Share & Forecast
    - 6.3.3.2.1. By Nanomolecule Type
    - 6.3.3.2.2. By Nanoparticles Type
    - 6.3.3.2.3. By Application
    - 6.3.3.2.4. By Disease Indication

7. Europe Nanomedicine Market Outlook

7.1. Market Size & Forecast
- 7.1.1. By Value
7.2. Market Share & Forecast
- 7.2.1. By Nanomolecule Type
- 7.2.2. By Nanoparticles Type
- 7.2.3. By Application
- 7.2.4. By Disease Indication
- 7.2.5. By Country
7.3. Europe: Country Analysis
- 7.3.1. Germany Nanomedicine Market Outlook
  - 7.3.1.1. Market Size & Forecast
    - 7.3.1.1.1. By Value
  - 7.3.1.2. Market Share & Forecast
    - 7.3.1.2.1. By Nanomolecule Type
    - 7.3.1.2.2. By Nanoparticles Type
    - 7.3.1.2.3. By Application
    - 7.3.1.2.4. By Disease Indication
- 7.3.2. France Nanomedicine Market Outlook
  - 7.3.2.1. Market Size & Forecast
    - 7.3.2.1.1. By Value
  - 7.3.2.2. Market Share & Forecast
    - 7.3.2.2.1. By Nanomolecule Type
    - 7.3.2.2.2. By Nanoparticles Type
    - 7.3.2.2.3. By Application
    - 7.3.2.2.4. By Disease Indication
- 7.3.3. United Kingdom Nanomedicine Market Outlook
  - 7.3.3.1. Market Size & Forecast
    - 7.3.3.1.1. By Value
  - 7.3.3.2. Market Share & Forecast
    - 7.3.3.2.1. By Nanomolecule Type
    - 7.3.3.2.2. By Nanoparticles Type
    - 7.3.3.2.3. By Application
    - 7.3.3.2.4. By Disease Indication
- 7.3.4. Italy Nanomedicine Market Outlook
  - 7.3.4.1. Market Size & Forecast
    - 7.3.4.1.1. By Value
  - 7.3.4.2. Market Share & Forecast
    - 7.3.4.2.1. By Nanomolecule Type
    - 7.3.4.2.2. By Nanoparticles Type
    - 7.3.4.2.3. By Application
    - 7.3.4.2.4. By Disease Indication
- 7.3.5. Spain Nanomedicine Market Outlook
  - 7.3.5.1. Market Size & Forecast
    - 7.3.5.1.1. By Value
  - 7.3.5.2. Market Share & Forecast
    - 7.3.5.2.1. By Nanomolecule Type
    - 7.3.5.2.2. By Nanoparticles Type
    - 7.3.5.2.3. By Application
    - 7.3.5.2.4. By Disease Indication

8. Asia Pacific Nanomedicine Market Outlook

8.1. Market Size & Forecast
- 8.1.1. By Value
8.2. Market Share & Forecast
- 8.2.1. By Nanomolecule Type
- 8.2.2. By Nanoparticles Type
- 8.2.3. By Application
- 8.2.4. By Disease Indication
- 8.2.5. By Country
8.3. Asia Pacific: Country Analysis
- 8.3.1. China Nanomedicine Market Outlook
  - 8.3.1.1. Market Size & Forecast
    - 8.3.1.1.1. By Value
  - 8.3.1.2. Market Share & Forecast
    - 8.3.1.2.1. By Nanomolecule Type
    - 8.3.1.2.2. By Nanoparticles Type
    - 8.3.1.2.3. By Application
    - 8.3.1.2.4. By Disease Indication
- 8.3.2. India Nanomedicine Market Outlook
  - 8.3.2.1. Market Size & Forecast
    - 8.3.2.1.1. By Value
  - 8.3.2.2. Market Share & Forecast
    - 8.3.2.2.1. By Nanomolecule Type
    - 8.3.2.2.2. By Nanoparticles Type
    - 8.3.2.2.3. By Application
    - 8.3.2.2.4. By Disease Indication
- 8.3.3. Japan Nanomedicine Market Outlook
  - 8.3.3.1. Market Size & Forecast
    - 8.3.3.1.1. By Value
  - 8.3.3.2. Market Share & Forecast
    - 8.3.3.2.1. By Nanomolecule Type
    - 8.3.3.2.2. By Nanoparticles Type
    - 8.3.3.2.3. By Application
    - 8.3.3.2.4. By Disease Indication
- 8.3.4. South Korea Nanomedicine Market Outlook
  - 8.3.4.1. Market Size & Forecast
    - 8.3.4.1.1. By Value
  - 8.3.4.2. Market Share & Forecast
    - 8.3.4.2.1. By Nanomolecule Type
    - 8.3.4.2.2. By Nanoparticles Type
    - 8.3.4.2.3. By Application
    - 8.3.4.2.4. By Disease Indication
- 8.3.5. Australia Nanomedicine Market Outlook
  - 8.3.5.1. Market Size & Forecast
    - 8.3.5.1.1. By Value
  - 8.3.5.2. Market Share & Forecast
    - 8.3.5.2.1. By Nanomolecule Type
    - 8.3.5.2.2. By Nanoparticles Type
    - 8.3.5.2.3. By Application
    - 8.3.5.2.4. By Disease Indication

9. Middle East & Africa Nanomedicine Market Outlook

9.1. Market Size & Forecast
- 9.1.1. By Value
9.2. Market Share & Forecast
- 9.2.1. By Nanomolecule Type
- 9.2.2. By Nanoparticles Type
- 9.2.3. By Application
- 9.2.4. By Disease Indication
- 9.2.5. By Country
9.3. Middle East & Africa: Country Analysis
- 9.3.1. Saudi Arabia Nanomedicine Market Outlook
  - 9.3.1.1. Market Size & Forecast
    - 9.3.1.1.1. By Value
  - 9.3.1.2. Market Share & Forecast
    - 9.3.1.2.1. By Nanomolecule Type
    - 9.3.1.2.2. By Nanoparticles Type
    - 9.3.1.2.3. By Application
    - 9.3.1.2.4. By Disease Indication
- 9.3.2. UAE Nanomedicine Market Outlook
  - 9.3.2.1. Market Size & Forecast
    - 9.3.2.1.1. By Value
  - 9.3.2.2. Market Share & Forecast
    - 9.3.2.2.1. By Nanomolecule Type
    - 9.3.2.2.2. By Nanoparticles Type
    - 9.3.2.2.3. By Application
    - 9.3.2.2.4. By Disease Indication
- 9.3.3. South Africa Nanomedicine Market Outlook
  - 9.3.3.1. Market Size & Forecast
    - 9.3.3.1.1. By Value
  - 9.3.3.2. Market Share & Forecast
    - 9.3.3.2.1. By Nanomolecule Type
    - 9.3.3.2.2. By Nanoparticles Type
    - 9.3.3.2.3. By Application
    - 9.3.3.2.4. By Disease Indication

10. South America Nanomedicine Market Outlook

10.1. Market Size & Forecast
- 10.1.1. By Value
10.2. Market Share & Forecast
- 10.2.1. By Nanomolecule Type
- 10.2.2. By Nanoparticles Type
- 10.2.3. By Application
- 10.2.4. By Disease Indication
- 10.2.5. By Country
10.3. South America: Country Analysis
- 10.3.1. Brazil Nanomedicine Market Outlook
  - 10.3.1.1. Market Size & Forecast
    - 10.3.1.1.1. By Value
  - 10.3.1.2. Market Share & Forecast
    - 10.3.1.2.1. By Nanomolecule Type
    - 10.3.1.2.2. By Nanoparticles Type
    - 10.3.1.2.3. By Application
    - 10.3.1.2.4. By Disease Indication
- 10.3.2. Colombia Nanomedicine Market Outlook
  - 10.3.2.1. Market Size & Forecast
    - 10.3.2.1.1. By Value
  - 10.3.2.2. Market Share & Forecast
    - 10.3.2.2.1. By Nanomolecule Type
    - 10.3.2.2.2. By Nanoparticles Type
    - 10.3.2.2.3. By Application
    - 10.3.2.2.4. By Disease Indication
- 10.3.3. Argentina Nanomedicine Market Outlook
  - 10.3.3.1. Market Size & Forecast
    - 10.3.3.1.1. By Value
  - 10.3.3.2. Market Share & Forecast
    - 10.3.3.2.1. By Nanomolecule Type
    - 10.3.3.2.2. By Nanoparticles Type
    - 10.3.3.2.3. By Application
    - 10.3.3.2.4. By Disease Indication

11. Market Dynamics

11.1. Drivers
11.2. Challenges

12. Market Trends & Developments

12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments

13. Global Nanomedicine Market: SWOT Analysis

14. Porter's Five Forces Analysis

14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products

15. Competitive Landscape

15.1. Pfizer Inc.
- 15.1.1. Business Overview
- 15.1.2. Products & Services
- 15.1.3. Recent Developments
- 15.1.4. Key Personnel
- 15.1.5. SWOT Analysis
15.2. Johnson & Johnson Innovative Medicine
15.3. Sanofi S.A.
15.4. Amgen Inc.
15.5. Moderna, Inc.
15.6. Novo Nordisk A/S
15.7. Genentech, Inc.
15.8. Celgene Corporation
15.9. Vifor Pharma Group
15.10. Teva Pharmaceutical Industries Ltd.